Product Launches, Investor Conferences, Margin Expansions, and Acquisitions - Research Report on Nu Skin, Avon, Clorox, Estée

Product Launches, Investor Conferences, Margin Expansions, and Acquisitions -
 Research Report on Nu Skin, Avon, Clorox, Estée Lauder, and Prestige Brands

Editor Note: For more information about this release, please scroll to bottom.

PR Newswire

NEW YORK, August 6, 2013

NEW YORK, August 6, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Nu Skin
Enterprises, Inc. (NYSE: NUS), Avon Products, Inc. (NYSE: AVP), The Clorox Co.
(NYSE: CLX), Estée Lauder Companies Inc. (NYSE: EL), and Prestige Brands
Holdings, Inc. (NYSE: PBH). Today's readers may access these reports free of
charge - including full price targets, industry analysis and analyst ratings -
via the links below.

Nu Skin Enterprises, Inc. Research Report

On August 1, 2013, Nu Skin Enterprises, Inc. (Nu Skin) reported its Q2 2013
financial results. The Company's revenue increased 15.1% YoY to $682.9 million
during the quarter. Net income was $74.4 million or $1.22 per diluted share,
in Q2 2013 compared to net income of $60.4 million or $0.94 per diluted share,
in Q2 2012. Truman Hunt, President and CEO of Nu Skin said, "We are extremely
pleased with second-quarter results that reflect the strong momentum of the
business. We are particularly pleased with these results given the record
regional ageLOC product launches in the prior-year period. Additionally, we
generated continued growth of both our consumer and sales leader base,
reflected in 32 percent growth in actives and 23 percent growth in sales
leaders. Overall, we saw healthy trends throughout the global business,
particularly in the Greater China, North Asia and Americas regions." Nu Skin
updated its 2013 revenue guidance from previous $2.9 billion to approximately
$3.0 billion. The Full Research Report on Nu Skin Enterprises, Inc. -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.analystscorner.com/r/full_research_report/4acf_NUS]

--

Avon Products, Inc. Research Report

On August 1, 2013, Avon Products, Inc. (Avon) reported its Q2 2013 financial
results. According to the Company, total revenue decreased 2.0% YoY to $2.5
billion during the quarter. Net income attributable to Avon was $31.9 million
or $0.07 per diluted share, compared to $61.6 million or $0.14 per diluted
share in Q2 2012. Sheri McCoy, CEO of Avon, said, "Our second-quarter results
reflect continued progress in stabilizing Avon's business. There is still
significant work to be done to deliver sustainable performance in the near and
longer term, but I'm pleased with the progress to date. We will succeed by
continuing our focus on better serving Avon Representatives, creating a
compelling consumer proposition, and simplifying our business to drive both
top and bottom line improvements." The Full Research Report on Avon Products,
Inc. - including full detailed breakdown, analyst ratings and price targets -
is available to download free of charge at:
[http://www.analystscorner.com/r/full_research_report/676c_AVP]

--

The Clorox Co. Research Report

On August 1, 2013, The Clorox Co. (Clorox) reported its financial results for
Q4 FY 2013 and FY 2013 (period ended June 30, 2013). For Q4 FY 2013, the
Company's net sales increased 0.4% YoY to $1.5 billion. Net earnings were $183
million or $1.37 per diluted share, compared to net earnings of $174 million
or $1.32 per diluted share, in Q4 FY 2012. For FY 2013, net sales increased
2.8% YoY to $5.6 billion. Net earnings were $572 million or $4.30 per diluted
share, compared to net earnings of $541 million or $4.09 per diluted share, in
FY 2012. Chairman and CEO of Clorox, Don Knauss, said, "We grew sales in all
four segments behind product innovation across multiple brands and delivered
strong gross margin expansion." For full year 2014, Clorox expects sales to
grow by 2% to 4% and diluted EPS to be within $4.55 to $4.70. The Full
Research Report on The Clorox Co. - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:
[http://www.analystscorner.com/r/full_research_report/4ebb_CLX]

--

Estée Lauder Companies Inc. Research Report 

On August 1, 2013, The Estée Lauder Companies Inc. (Estée Lauder) announced
that it will release its Q4 FY 2013 and FY 2013 financial results on Thursday,
August 15, 2013. The Company also informed that on the same date at 9:00 a.m.,
Estée Lauder will host a live webcast of its conference call to discuss the
results, future prospects, and any recent corporate developments. In a prior
announcement on May 2, 2013, the Company released its outlook for FY 2013. The
Company expects net sales to grow approximately 6% in constant currency.
Further, the Company expects diluted net earnings per share before charges
associated with restructuring activities and the impact of early
extinguishment of debt to be in the range of $2.56 to $2.61. The Full Research
Report on Estée Lauder Companies Inc. - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at: [http://www.analystscorner.com/r/full_research_report/5d80_EL]

--

Prestige Brands Holdings, Inc. Research Report

On August 1, 2013, Prestige Brands Holdings, Inc. (Prestige Brands) reported
its financial results for Q1 FY 2014 (period ended June 30, 2013). The
Company's total revenues decreased 2.7% YoY to $143.0 million during the
quarter. Net income was $20.7 million or $0.40 per diluted share in Q1 FY
2014, compared to net income of $14.7 million or $0.29 per diluted share in Q2
FY 2013. Matthew Mannelly, CEO of Prestige Brands, said, "We are pleased with
our performance in the first quarter against our stated strategy to create
long-term shareholder value through continued earnings per share growth. In
addition, we executed against our M&A strategy with the acquisition of Care
Pharmaceuticals, an OTC healthcare products company from New South Wales,
Australia." The Full Research Report on Prestige Brands Holdings, Inc. -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.analystscorner.com/r/full_research_report/09be_PBH]

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA. However, we are only human and are prone to
    make mistakes. If you notice any errors or omissions, please notify us
    below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

AnalystsCorner.com

SOURCE Analysts' Corner

Contact: Joe Thomas, +1-310-496-8071 (North America)
 
Press spacebar to pause and continue. Press esc to stop.